Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program
- PMID: 22925970
- PMCID: PMC3705555
- DOI: 10.1016/j.cct.2012.08.008
Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program
Abstract
Background: The translation of research evidence into practice is facilitated by clinical trials such as those sponsored by the National Cancer Institute's Community Clinical Oncology Program (CCOP) that help disseminate cancer care innovations to community-based physicians and provider organizations. However, CCOP participation involves unsubsidized costs and organizational challenges that raise concerns about sustained provider participation in clinical trials.
Objectives: This study was designed to improve our understanding of why providers participate in the CCOP in order to inform the decision-making process of administrators, clinicians, organizations, and policy-makers considering CCOP participation.
Research methods: We conducted a multi-site qualitative study of five provider organizations engaged with the CCOP. We interviewed 41 administrative and clinician key informants, asking about what motivated CCOP participation, and what benefits they associated with involvement. We deductively and inductively analyzed verbatim interview transcripts, and explored themes that emerged.
Results: Interviewees expressed both "altruistic" and "self-interested" motives for CCOP participation. Altruistic reasons included a desire to increase access to clinical trials and feeling an obligation to patients. Self-interested reasons included the desire to enhance reputation, and a need to integrate disparate cancer care activities. Perceived benefits largely matched expressed motives for CCOP participation, and included internal and external benefits to the organization, and quality of care benefits for both patients and participating physicians.
Conclusion: The motives and benefits providers attributed to CCOP participation are consistent with translational research goals, offering evidence that participation can contribute value to providers by expanding access to innovative medical care for patients in need.
Copyright © 2012 Elsevier Inc. All rights reserved.
Conflict of interest statement
No conflict of interest exists with this manuscript.
Similar articles
-
Challenges and facilitators of community clinical oncology program participation: a qualitative study.J Healthc Manag. 2013 Jan-Feb;58(1):29-44; discussion 45-6. J Healthc Manag. 2013. PMID: 23424817 Free PMC article.
-
Implementing community-based provider participation in research: an empirical study.Implement Sci. 2012 May 8;7:41. doi: 10.1186/1748-5908-7-41. Implement Sci. 2012. PMID: 22568935 Free PMC article.
-
A method for analyzing the business case for provider participation in the National Cancer Institute's Community Clinical Oncology Program and similar federally funded, provider-based research networks.Cancer. 2012 Sep 1;118(17):4253-61. doi: 10.1002/cncr.27375. Epub 2011 Dec 27. Cancer. 2012. PMID: 22213241 Free PMC article.
-
The NCI Community Oncology Research Program: what every clinician needs to know.Am Soc Clin Oncol Educ Book. 2013. doi: 10.14694/EdBook_AM.2013.33.e84. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714464 Review.
-
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.J Oncol Pract. 2013 Nov;9(6):267-76. doi: 10.1200/JOP.2013.001119. Epub 2013 Oct 15. J Oncol Pract. 2013. PMID: 24130252 Free PMC article.
Cited by
-
Music Therapist Experiences of a Randomized Controlled Trial as Clinician Researchers.J Music Ther. 2020 Jul 18;57(3):315-352. doi: 10.1093/jmt/thaa005. J Music Ther. 2020. PMID: 32227108 Free PMC article.
-
Tracing the potential of networks to improve community cancer care: an in-depth single case study.Implement Sci Commun. 2021 Aug 25;2(1):92. doi: 10.1186/s43058-021-00190-1. Implement Sci Commun. 2021. PMID: 34433489 Free PMC article.
-
Site Principal Investigators in Multicenter Clinical Trials: Appropriately Recognizing Key Contributors.Circulation. 2017 Mar 28;135(13):1185-1187. doi: 10.1161/CIRCULATIONAHA.116.026650. Circulation. 2017. PMID: 28348087 Free PMC article. No abstract available.
-
Pharmacist-Led Deprescribing of Opioids and Benzodiazepines in Older Adults: Examining Implementation and Perceptions.Pharmacy (Basel). 2024 Jul 30;12(4):119. doi: 10.3390/pharmacy12040119. Pharmacy (Basel). 2024. PMID: 39195848 Free PMC article.
-
Attitudes of small animal practitioners toward participation in veterinary clinical trials.J Am Vet Med Assoc. 2017 Jan 1;250(1):86-97. doi: 10.2460/javma.250.1.86. J Am Vet Med Assoc. 2017. PMID: 28001115 Free PMC article.
References
-
- Zerhouni E. Translational and clinical science - time for a new vision. N Engl J Med. 2005;353:1621–3. - PubMed
-
- Zerhouni E. US biomedical research: basic, translational, and clinical sciences. J Am Med Assoc. 2005;294:1352–58. - PubMed
-
- Lenfant C. Shattuck lecture--clinical research to clinical practice--lost in translation? N Engl J Med. 2003;349:868–74. - PubMed
-
- Lamb S, Greenlick MR, McCarty D. Bridging the Gap Between Practice and Research. Washington, DC: National Academy Press; 1998. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical